Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy
Status:
Recruiting
Trial end date:
2022-04-22
Target enrollment:
Participant gender:
Summary
Study to assess the anti-hypertensive efficacy and safety of the extemporaneous combination
of Zofenopril 30 mg in combination with Amlodipine 5 mg or AML 10 mg in lowering the sitting
diastolic BP after 8 weeks of treatment in patients with uncontrolled BP previously treated
with Zofenopril or Amlodipine (5 mg) monotherapies for at least 4 weeks.